Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
Adrienne Hammill, MD |
Hammill BVMC 6203 U54 per patient HHR UCSF |
The Regents of the Univ of California (Ntl Inst of Neuro Disorders & Stroke) National Institues of Health (NIH) |
11614sc |
7/1/2019-6/30/2021 |
$55,968 |
Adrienne Hammill, MD |
Hammill BVMC UCSF Per Patient 6211 |
The Regents of the Univ of California (Ntl Inst of Neuro Disorders & Stroke) National Institues of Health (NIH) |
11573SC |
7/1/2020-6/30/2021 |
$3,975 |
Anthony J Sabulski, MD |
Mechanisms and Consequences of BK Polyomavirus Infection in Immunocompromised Patients |
Thrasher Research Fund |
Sabulski, Anthony, T |
1/1/2021-12/31/2021 |
$14,715 |
Brenton Francisco, MD |
The Role of hemostatic regulators in osteosarcoma metastasis |
Cancer Free Kids |
Fransisco, B., CFK |
7/1/2020-6/30/2021 |
$50,000 |
Brenton Francisco, MD |
Mechanisms Coupling Hemostatic Factors to Osteosarcoma Metastasis |
Hyundai Hope on Wheels |
HHOW |
7/1/2020-6/30/2021 |
$100,000 |
Charles T Quinn, MD |
Immune Thrombocytopenia (ITP) Bleeding Emergencies: A Cohort Study |
McMaster Children's Hospital (Canadian Institute of Health Research) |
Quinn, CTA, CIRF, MC |
3/31/2021-8/31/2025 |
$6,839 |
Cristina Tarango, MD |
Region V East Comprehensive Care Network for Bleeding D |
Hemophilia Foundation of Michigan (Maternal & Child Health Bureau) |
H30MC24047 |
6/1/2020-5/31/2021 |
$22,000 |
Cristina Tarango, MD |
Community Counts: Public Health Surveillance for Bleedin |
Hemophilia Foundation of Michigan (Ctr for Disease Control and Prevention) |
U27DD001155 |
9/30/2020-9/29/2021 |
$27,250 |
Cristina Tarango, MD |
Tarango ATHN 12 |
American Thrombosis & Hemostatis Network |
433 |
9/1/2020-8/31/2021 |
$20,000 |
Eric Mullins, MD |
Mechanisms linking hemostatic factors and neuroinflammatorydisease |
Ntl Inst of Neuro Disorders & Stroke National Institues of Health (NIH) |
R01NS107258 |
3/1/2021-2/28/2022 |
$412,354 |
Lisa M Littner, LISW-S |
Littner CARE June 2020 |
American Thrombosis & Hemostatis Network |
ATHN2020-CARE1-433-1 |
10/1/2020-9/30/2021 |
$50,000 |
Lisa M Shook |
Sickle Treatment and Outcomes Research in the Midwest (S |
Health Resources & Services Admin |
U1EMC27863 |
9/1/2020-8/31/2021 |
$760,750 |
Lisa M Shook |
Shook ODH FY20 Deliverable |
Ohio Department of Health |
03130011SK1320 |
7/1/2020-6/30/2021 |
$133,668 |
Luke R Smart, MD |
Sickle Cell Anemia, Splenic Pathology, and Hydroxyurea in Sub-Saharan Africa |
National Heart, Lung & Blood Institute National Institues of Health (NIH) |
K23HL153763 |
7/21/2020-6/30/2021 |
$169,560 |
Luke R Smart, MD |
Comprehensive care for infants with sickle cell disease born in rural Tanazania |
American Academy of Pediatrics |
Smart, Luke, AAP |
7/1/2020-6/30/2021 |
$2,000 |
Luke R Smart, MD |
A concept for Gene Therapy for Sickle Cell Anemia |
Univ of North Carolina at Chapel Hill (Ntl Inst of Allergy & Infections Dis) National Institues of Health (NIH) |
5119391 |
8/1/2020-7/31/2021 |
$29,412 |
Omar Y. Niss, MD |
Community Health Workers and mHealth for Sickle Cell Disease |
Children's Hospital of Philadelphia (Patient-Centered Outcome Research Inst.) |
4261420324 |
3/1/2019-2/28/2022 |
$419,572 |
Patrick McGann, MD, MS |
Maximizing Fetal Hemoglobin Responses to Hydroxyurea using Precision Medicine |
Doris Duke Charitable Foundation |
2017090 |
9/1/2019-8/31/2022 |
$69,500 |
Patrick McGann, MD, MS |
Hydroxyurea Pharmacokinetics in Adults with Sickle Cell Anemia |
American Society of Hematology |
McGann_ASH |
7/1/2020-6/30/2021 |
$75,000 |
Russell Ware, MD, PhD |
Realizing Effectiveness Across Continents with Hydroxyur |
National Heart, Lung & Blood Institute National Institues of Health (NIH) |
U01HL133883 |
8/1/2020-7/31/2021 |
$676,152 |
Theodosia A Kalfa, MD, PhD |
The Role of Erythroblastic Islands in Anemia of Inflammation |
National Heart, Lung & Blood Institute National Institues of Health (NIH) |
R01HL152099 |
4/1/2021-3/31/2022 |
$619,934 |
Total Annual Grant Award Dollars |
$3,718,649 |